Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to accelerate and de-risk drug research and development, today announced four of their posters are accepted to present at ACoP9 occuring October 7-10, 2018 in San Diego, CA. 

Fei Hua, PhD, Senior Director Modeling & Simulation and Clinical Pharmacology, Applied BioMath is presenting a poster Monday, October 8, 2018 (M-058) titled "Quantitative Systems Pharmacology Models Predict Optimal Drug Properties and Inform Translation from Mice to Human in Retinal Degenerative Disease." This poster features the work of Applied BioMath's collaboration with Shire Pharmaceuticals. 

Liming Zhang, PhD, Associate Scientific Director, Takeda is presenting a poster Tuesday, October 9, 2018 (T-057) titled "A Quantitative Systems Pharmacology Model of Colonic Motility to Aid Drug Discovery and Development." This poster features the work of Applied BioMath's collaboration with Takeda. 

Lore Gruenbaum, PhD, Executive Director of Biology and Pharmacology, Applied BioMath is presenting a poster Tuesday, October 9, 2018 (T-058) titled "Quantitative Systems Pharmacology Model of Amyloid Beta and Plaque Dynamics in Alzheimer's Disease upon Treatment with Anti-Amyloid Beta Drugs Crenezumab, Solanezumab, and Bapineuzumab." This poster features research that supports the grant Applied BioMath was awarded in October 2017 by the National Institute on Aging of the NIH for the development of a systems pharmacology model in Alzheimer's Disease and Dementia. 

Yan Ji, PhD, Director of Clinical Pharmacology, Novartis is presenting a poster Wednesday, October 10, 2018 (W-069) titled "Quantitative Systems Pharmacology Model of Glucocorticoid-Induced TNFR-Related Protein (GITR)-Medicated T Cell Dynamics in Mouse Tumor Micro Environment." This poster features the work of Applied BioMath's collaboration with Novartis. 

"We are thrilled to showcase the work we have completed in collaboration with our partners and in support of our NIH grant," said John Burke, PhD, Co-Founder, President and CEO, Applied BioMath. "Our posters demonstrate the value that QSP delivers within various projects and we're excited to share this with the attendees at ACoP9."

In addition to presenting four posters, Applied BioMath will have a booth and present at dual sessions at the conference. For more information about Applied BioMath's presence at ACoP, visit https://www.appliedbiomath.com/news-resources/events/acop9

For more information about all Applied BioMath events, visit https://www.appliedbiomath.com/news-resources/events.